A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score
- PMID: 20738765
- DOI: 10.1111/j.1538-7836.2010.04044.x
A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score
Abstract
Background: Prophylaxis of venous thromboembolism (VTE) in hospitalized medical patients is largely underused. We sought to assess the value of a simple risk assessment model (RAM) for the identification of patients at risk of VTE.
Methods: In a prospective cohort study, 1180 consecutive patients admitted to a department of internal medicine in a 2-year period were classified as having a high or low risk of VTE according to a predefined RAM. They were followed-up for up to 90 days to assess the occurrence of symptomatic VTE complications. The primary study outcome was to assess the adjusted hazard ratio (HR) of VTE in high-risk patients who had adequate in-hospital thromboprophylaxis in comparison with those who did not, and that of VTE in the latter group in comparison with low-risk patients.
Results: Four hundred and sixty-nine patients (39.7%) were labelled as having a high risk of thrombosis. VTE developed in four of the 186 (2.2%) who received thromboprophylaxis, and in 31 of the 283 (11.0%) who did not (HR of VTE, 0.13; 95% CI, 0.04-0.40). VTE developed also in two of the 711 (0.3%) low-risk patients (HR of VTE in high-risk patients without prophylaxis as compared with low-risk patients, 32.0; 95% CI, 4.1-251.0). Bleeding occurred in three of the 186 (1.6%) high-risk patients who had thromboprophylaxis.
Conclusions: Our RAM can help discriminate between medical patients at high and low risk of VTE. The adoption of adequate thromboprophylaxis in high-risk patients during hospitalization leads to longstanding protection against thromboembolic events with a low risk of bleeding.
© 2010 International Society on Thrombosis and Haemostasis.
Comment in
-
A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score: a rebuttal.J Thromb Haemost. 2011 Jul;9(7):1437-8. doi: 10.1111/j.1538-7836.2011.04305.x. J Thromb Haemost. 2011. PMID: 21501378 No abstract available.
Similar articles
-
Rate and predictors of thromboprophylaxis in internal medicine wards: Results from the AURELIO study.Thromb Res. 2024 Nov;243:109148. doi: 10.1016/j.thromres.2024.109148. Epub 2024 Sep 11. Thromb Res. 2024. PMID: 39326194
-
Multicentre validation of the Geneva Risk Score for hospitalised medical patients at risk of venous thromboembolism. Explicit ASsessment of Thromboembolic RIsk and Prophylaxis for Medical PATients in SwitzErland (ESTIMATE).Thromb Haemost. 2014 Mar 3;111(3):531-8. doi: 10.1160/TH13-05-0427. Epub 2013 Nov 14. Thromb Haemost. 2014. PMID: 24226257 Clinical Trial.
-
Clinical impact of application of risk assessment models (Padua Prediction Score and Improve Bleeding Score) on venous thromboembolism, major hemorrhage and health expenditure associated with pharmacologic VTE prophylaxis: a "real life" prospective and retrospective observational study on patients hospitalized in a Single Internal Medicine Unit (the STIME study).Intern Emerg Med. 2018 Jun;13(4):527-534. doi: 10.1007/s11739-018-1808-z. Epub 2018 Mar 3. Intern Emerg Med. 2018. PMID: 29502330
-
Updated clinical models for VTE prediction in hospitalized medical patients.Thromb Res. 2018 Apr;164 Suppl 1:S62-S69. doi: 10.1016/j.thromres.2018.02.004. Thromb Res. 2018. PMID: 29703486 Review.
-
Extended thromboprophylaxis with low-molecular-weight heparins after hospital discharge in high-risk surgical and medical patients: a review.Clin Ther. 2009 Jun;31(6):1129-41. doi: 10.1016/j.clinthera.2009.06.002. Clin Ther. 2009. PMID: 19695383 Review.
Cited by
-
Upper Extremity Deep Vein Thrombosis: Incidence, Risk Factors, and Effectiveness of Chemoprophylaxis.South Med J. 2024 Sep;117(9):534-538. doi: 10.14423/SMJ.0000000000001728. South Med J. 2024. PMID: 39227045
-
Genetic factors, risk prediction and AI application of thrombotic diseases.Exp Hematol Oncol. 2024 Aug 27;13(1):89. doi: 10.1186/s40164-024-00555-x. Exp Hematol Oncol. 2024. PMID: 39192370 Free PMC article. Review.
-
The Use of Risk Scores for Thromboprophylaxis in Medically Ill Patients-Rationale and Design of the RICO trial.TH Open. 2024 Jan 12;8(1):e55-e60. doi: 10.1055/a-2209-4708. eCollection 2024 Jan. TH Open. 2024. PMID: 38222040 Free PMC article.
-
Highlights from the IV International Symposium of Thrombosis and Anticoagulation (ISTA), October 20-21, 2011, Salvador, Bahia, Brazil.J Thromb Thrombolysis. 2012 Jul;34(1):143-63. doi: 10.1007/s11239-012-0700-3. J Thromb Thrombolysis. 2012. PMID: 22427055
-
Prioritizing cardiovascular surgical care in COVID-19 pandemic: Shall we operate or defer?J Card Surg. 2020 Oct;35(10):2768-2772. doi: 10.1111/jocs.14864. Epub 2020 Jul 15. J Card Surg. 2020. PMID: 32668048 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical